ArticleBioinformatics (Oxford, England)2026
Predicting antibody-antigen affinity with a dual-level representation model.
Article in Bioinformatics (Oxford, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
motivationProtein language models are critical for modeling antibody-antigen interactions, yet sequence-based affinity prediction remains a key challenge, particularly when structural data are scarce. Existing methods often struggle to fully exploit sequence information, limiting their applicability across diverse antibody formats such as single-domain antibodies (sdAbs).
resultsWe propose dual-level protein representation for affinity prediction (DLP-Affinity), a dual-level deep learning framework for accurate sequence-based affinity prediction. It leverages two complementary modules: residue-to-residue to capture local interface contacts, and global stochastic projection embedding to represent global protein properties. Utilizing a fine-tuned protein language model, our approach achieves state-of-the-art performance on the general AB-Bind dataset (reducing mean absolute error by up to 20.9%) and delivers highly competitive results on the sdAb-DB dataset. This provides a robust tool for sequence-based antibody affinity prediction. AVAILABILITY AND IMPLEMENTATION: The source code and datasets for DLP-Affinity are freely available at https://github.com/Zy-Wang-bit/DLP_Affinity and archived on Zenodo at https://doi.org/10.5281/zenodo.18437656.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.